Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FKBP12 inhibitors in the pipeline at Guilford

Aug. 29, 1997

New Parkinson's disease treatment option now available in Canada

Aug. 28, 1997

Morphine derivatives discovered by Nycomed

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Aug. 28, 1997

Immune Response's TCR vaccine evaluated in MS patients

Aug. 28, 1997

Calcium channel antagonist AJ-3941 for treatment of stroke

Aug. 27, 1997

S-15535 tested in preclinical models of anxiety and depression

Aug. 27, 1997

New treatment option for cancer pain

Aug. 27, 1997

Cognition enhancer found devoid of neurotoxicity in vitro

Aug. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...